Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs

Health
By Dani Blum and Rebecca Robbins from NYT Health https://ift.tt/1vWdGla
via IFTTT Diet and Nutrition, United States Politics and Government, Weight, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, GLP-1 RAs (Drug), Regulation and Deregulation of Industry, Diabetes, Ozempic (Drug), Medicare The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda